Page last updated: 2024-08-23

piperacillin and Antibiotic-Associated Colitis

piperacillin has been researched along with Antibiotic-Associated Colitis in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19901 (9.09)18.7374
1990's1 (9.09)18.2507
2000's7 (63.64)29.6817
2010's2 (18.18)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Karlowsky, JA; Laing, NM; Zhanel, GG1
Joundi, RA; Leis, JA; Wong, BM1
Cadnum, JL; Donskey, CJ; Jury, LA; Kundrapu, S; Musuuza, JS; Nerandzic, MM; Sethi, AK; Sunkesula, VC1
Donskey, CJ; Koski, P; Nerandzic, MM; Stiefel, U1
Ahern, JW; Alston, WK1
Gibbs, L; Guglielmo, BJ; Jacobs, RA; McCulloch, CE; Mendez, MN; Winston, L1
Ernst, ME; Philbrick, AM1
Corrado, OJ; Fawley, WN; Hawkey, PM; Settle, CD; Wilcox, MH1
Freeman, J; Wilcox, MH1
Brown, A; Freeman, J; Wilcox, MH1
Hancock, KC; Harrison, CR; Satin, AJ; Zahn, CM1

Trials

1 trial(s) available for piperacillin and Antibiotic-Associated Colitis

ArticleYear
Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam.
    Alimentary pharmacology & therapeutics, 1998, Volume: 12, Issue:12

    Topics: Aged; beta-Lactamase Inhibitors; Cefotaxime; Clostridioides difficile; Cross Infection; Cross-Over Studies; Diarrhea; Drug Combinations; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Female; Humans; Male; Opportunistic Infections; Penicillanic Acid; Piperacillin; Prospective Studies; Tazobactam

1998

Other Studies

10 other study(ies) available for piperacillin and Antibiotic-Associated Colitis

ArticleYear
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
    Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11

    Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests

2008
Antibiotics "just-in-case" in a patient with aspiration pneumonitis.
    JAMA internal medicine, 2015, Volume: 175, Issue:4

    Topics: Anti-Bacterial Agents; Cerebral Palsy; Clostridioides difficile; Enterocolitis, Pseudomembranous; Epilepsy, Tonic-Clonic; Fatal Outcome; Humans; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Radiography; Vancomycin

2015
Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
    BMC infectious diseases, 2016, Apr-18, Volume: 16

    Topics: Anti-Bacterial Agents; Clostridioides difficile; Enterocolitis, Pseudomembranous; Feces; Hospitals; Humans; Intestines; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Risk Factors; Tazobactam

2016
Orally administered beta-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile.
    The Journal of antimicrobial chemotherapy, 2008, Volume: 62, Issue:5

    Topics: Administration, Oral; Ampicillin; Animals; Bacterial Proteins; Bacterial Toxins; beta-Lactamases; Clostridioides difficile; DNA Fingerprinting; DNA, Bacterial; Electrophoresis, Polyacrylamide Gel; Enterocolitis, Pseudomembranous; Female; Gastrointestinal Contents; Mice; Nucleic Acid Denaturation; Piperacillin; RNA, Ribosomal

2008
Increase in the rate of nosocomial Clostridium difficile-associated diarrhoea during shortages of piperacillin-tazobactam and piperacillin.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:3

    Topics: Clostridioides difficile; Cross Infection; Diarrhea; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Humans; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; United States

2004
Impact of a piperacillin-tazobactam shortage on antimicrobial prescribing and the rate of vancomycin-resistant enterococci and Clostridium difficile infections.
    Pharmacotherapy, 2006, Volume: 26, Issue:1

    Topics: Anti-Bacterial Agents; California; Clostridioides difficile; Cross Infection; Drug Prescriptions; Drug Utilization; Enterococcus; Enterocolitis, Pseudomembranous; Gram-Positive Bacterial Infections; Humans; Length of Stay; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; United States; Vancomycin Resistance

2006
Amoxicillin-associated hemorrhagic colitis in the presence of Klebsiella oxytoca.
    Pharmacotherapy, 2007, Volume: 27, Issue:11

    Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Klebsiella Infections; Klebsiella oxytoca; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sinusitis

2007
Ureidopenicillins and risk of Clostridium difficile infection.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 47, Issue:5

    Topics: Ampicillin; Clostridioides difficile; Clostridium Infections; Enterocolitis, Pseudomembranous; Humans; Penicillins; Piperacillin; Risk Factors

2001
Faecal concentrations of piperacillin and tazobactam in elderly patients.
    The Journal of antimicrobial chemotherapy, 2001, Volume: 48, Issue:1

    Topics: Aged; Aged, 80 and over; Clostridioides difficile; Enterocolitis, Pseudomembranous; Enzyme Inhibitors; Feces; Female; Humans; Male; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam

2001
Relapsing Clostridium difficile toxin-associated colitis in ovarian cancer patients treated with chemotherapy.
    Obstetrics and gynecology, 1989, Volume: 74, Issue:3 Pt 2

    Topics: Aged; Ampicillin; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clindamycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Gentamicins; Humans; Middle Aged; Ovarian Neoplasms; Piperacillin; Recurrence

1989